Tag: HFpEF
Systemic delivery of extracellular vesicles reduces AF in heart failure with...
A recent study has provided new mechanistic insights identifying distinct atrial electrophysiological remodelling and fibrosis-associated conduction abnormalities favouring atrial fibrillation (AF) susceptibility in heart...
UK regulator approves dapagliflozin for use in heart failure across the...
AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin (Forxiga) in Great Britain...